[BRAF融合在非小细胞肺癌中的研究进展]
1Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|November 21, 2023
概括
在非小细胞肺癌 (NSCLC) 中,越来越多地检测到BRAF融合. 本综述探讨了BRAF融合的临床特征,机制和治疗方法,旨在指导未来的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 病毒性瘤基因同源B1 (BRAF) 突变与晚期非小细胞肺癌 (NSCLC) 的预后不佳有关.
- 目前的治疗方法,如达布拉芬尼 (Dabrafenib) 加上特拉美丁尼 (Trametinib),针对特定的BRAF突变 (例如V600E).
- 不同于突变的BRAF融合正在成为NSCLC中临床相关的改变.
结论:
- BRAF融合需要特定的诊断方法和量身定制的治疗干预措施.
- 对BRAF融合生物学的进一步研究将为开发新型治疗提供信息.
- 本综述为管理BRAF融合的NSCLC患者提供了基础.
更多相关视频
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
1.1K
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
9.6K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K